A Sequence of the CIS Gene Promoter Interacts Preferentially with Two Associated STAT5A Dimers: a Distinct Biochemical Difference between STAT5A and STAT5B
Frédèrique Verdier(Université Paris Cité), Stany Chrétien(Hôpital Necker-Enfants Malades), O. Müller(Centre National de la Recherche Scientifique), Patrick Mayeux(Université Paris Cité), Sylvie Gisselbrecht(Institut Cochin), P. Varlet(Inserm), Christian Beisenherz-Huss(University of Freiburg), Fabrice Gouilleux(Université de Tours), Catherine Lacombe(Centre National de la Recherche Scientifique), Raquel Rabionet(Institut Cochin)
Cited by 158
Related Papers
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Pure Red-Cell Aplasia and Antierythropoietin Antibodies in Patients Treated with Recombinant Erythropoietin
|New England Journal of Medicine|2002|1.2k
Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription.
|The EMBO Journal|1994|598
Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
|Blood|2015|383
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
|Haematologica|2009|316